Background: Total hip arthroplasty or total knee arthroplasty (THA/TKA) is often associated with varying degrees of pain. In recent years, transdermal buprenorphine (TDB) patch has shown encouraging ...

News, July 09, 2010 FDA Approves 7-Day Buprenorphine Pain Patch The FDA has approved a once-weekly buprenorphine transdermal system for the management of moderate to severe chronic pain in ...

The NIH study finds that those who had higher-than-recommended doses had more time until an emergency department or inpatient ...

intense pain and anxiety that resolves within a few hours. A new review of the best available evidence has found that the rate of buprenorphine-precipitated withdrawal in adults with opioid use ...

Traditional escalating pure mu-opioid receptor agonists and adjuvant neuropathic pain cocktails often have disappointing efficacy in the treatment of resistant PLP. We suggest introducing ...

Buprenorphine, commonly known by the brand name Suboxone, can cause “precipitated withdrawal” if not administered correctly, potentially causing pain, anxiety, sweating, and gastrointestinal ...

Seattle is the first city with first responders equipped and allowed to administer the opioid use disorder drug, ...

Figure 1. Additional therapies prescribed alongside buprenorphine for chronic pain management. Among the 248 patients enrolled, 118 with severe pain and 34 with moderate pain were prescribed adjuvant ...

wales.nhs.uk Objectives To assess the effectiveness and tolerability of buprenorphine for cancer pain in adults and children. Methods We searched CENTRAL, MEDLINE, EMBASE, ISI Web of Science, ISI ...

Traditional escalating pure mu-opioid receptor agonists and adjuvant neuropathic pain cocktails often have disappointing efficacy in the treatment of resistant PLP. We suggest introducing ...